QLIFE PUBLISHES ANNUAL REPORT 2020

An eventful and encouraging year with a positive transformation

Qlife Holding AB’s Annual report 2021 is from today available in swedish and english on the company’s website, www.qlifeholding.com.

https://qlifeholding.com/sv/investerare/finansiella-rapporter

https://qlifeholding.com/en/investors/finansiella-rapporter

The report can be downloaded from the website or ordered via the company; info@Egoo.health.

For more information please contact:

Thomas Warthoe, CEO
tw@egoo.health
+45 21 63 35 34

Qlife is a medical device company that seeks to revolutionize the clinical biomarker market for whole blood testing by taking it out of the lab and into the homes. This will facilitate easy access to blood sample results and in turn facilitate increased monitoring of parameters that enables care improvement.

Shares for Qlife are being traded on Nasdaq First North Growth Market in Stockholm with G&W Fondkommission as certified advisor (phone: +46 (0) 8-503 000 50, e-mail: ca@gwkapital.se).

Read more on Egoo.health, Qlifeholding.com or follow us on LinkedIn.